← Back to Search

Masimo SafetyNet Alert (MSNA) for Opioid Use Disorder

N/A
Recruiting
Research Sponsored by Masimo Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-4 weeks
Awards & highlights

Study Summary

This trial will test if using a device called Masimo SafetyNet Alert (MSNA) to monitor oxygen levels is practical and acceptable in a program that provides housing support.

Who is the study for?
This trial is for individuals in a supportive housing program who are dealing with opioid use disorder. The specific eligibility criteria to join the study have not been provided, so it's best to contact the research team for detailed requirements.Check my eligibility
What is being tested?
The study is testing how practical and acceptable it is to monitor oxygen levels using a device called Masimo SafetyNet Alert (MSNA) among people living in supportive housing and managing opioid use disorder.See study design
What are the potential side effects?
Since MSNA is a monitoring device, side effects may be minimal but could include skin irritation from wearing the device or anxiety related to continuous health monitoring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluation of acceptability of Masimo SafetyNet Alert (MSNA) in a supportive housing program
Evaluation of feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program
Evaluation of integration and expansion of Masimo SafetyNet Alert (MSNA) to similar housing environments

Trial Design

1Treatment groups
Experimental Treatment
Group I: Masimo SafetyNet Alert (MSNA)Experimental Treatment1 Intervention
All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo SafetyNet Alert (MSNA)

Find a Location

Who is running the clinical trial?

Masimo CorporationLead Sponsor
111 Previous Clinical Trials
13,062 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the ongoing medical study actively seeking participants at this time?

"Indeed, the information available on clinicaltrials.gov indicates that this particular clinical trial is actively seeking eligible candidates. The trial was initially posted on September 20th, 2023 and subsequently updated on January 11th, 2024. In order to complete the study successfully, a total of 15 patients are being sought from one research site."

Answered by AI

What is the overall participant count in this medical study?

"Indeed, the data available on clinicaltrials.gov indicates that this current clinical trial is actively seeking eligible participants. The study was first posted on September 20th, 2023 and was last updated on January 11th, 2024. In total, the trial aims to recruit 15 patients from a single designated location."

Answered by AI
~9 spots leftby Apr 2025